CMS implements prescription payment plan

Oct. 2024Important Notices

Your Medicare patients with high drug costs may benefit from participating in the Medicare Prescription Payment Plan, which will be available beginning on Jan. 1, 2025.

As part of the Inflation Reduction Act (IRA), all Medicare drug plans and Medicare health plans with drug coverage (such as Medicare Advantage plans) will be required to offer the Medicare Prescription Payment Plan. This new program will allow plan members to make monthly payments toward their out-of-pocket prescription drug costs over the course of the plan year instead of paying all at once at a pharmacy. (For more information on the IRA, please visit the CMS webpage about the Inflation Reduction Act and Medicare.

The Medicare Prescription Payment Plan will be available starting on Jan. 1, 2025. Program participants will pay $0 at their pharmacy for covered Part D medications, and Part D plan sponsors will bill participants each month for any cost sharing they incur while in the program. Pharmacies will be paid in full by the Part D plan sponsor in accordance with Part D prompt payment requirements. For more information about the program, please visit the Medicare Prescription Payment Plan page.

Medicare plan members who are likely to benefit from this program will receive information about how to enroll this fall.

If you have any questions about this matter, please contact your physician account executive or call Provider Services at 1-866-918-1595. As always, thank you for the excellent care you provide to our members.


Recent Announcements

CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care

Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.
Feb. 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Feb. 2026Education/Webinars

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates